List of Tables
Table 1. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Disease-Modifying Antirheumatic Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Disease-Modifying Antirheumatic Drug Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Disease-Modifying Antirheumatic Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Disease-Modifying Antirheumatic Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Disease-Modifying Antirheumatic Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Disease-Modifying Antirheumatic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Disease-Modifying Antirheumatic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Disease-Modifying Antirheumatic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Disease-Modifying Antirheumatic Drug Sales by Region (2019-2024) & (MT)
Table 18. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2019-2024)
Table 19. Global Disease-Modifying Antirheumatic Drug Sales by Region (2025-2030) & (MT)
Table 20. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2025-2030)
Table 21. Global Disease-Modifying Antirheumatic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Disease-Modifying Antirheumatic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Disease-Modifying Antirheumatic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Disease-Modifying Antirheumatic Drug Sales by Country (2019-2024) & (MT)
Table 27. North America Disease-Modifying Antirheumatic Drug Sales by Country (2025-2030) & (MT)
Table 28. North America Disease-Modifying Antirheumatic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Disease-Modifying Antirheumatic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Disease-Modifying Antirheumatic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2019-2024) & (MT)
Table 32. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2025-2030) & (MT)
Table 33. Europe Disease-Modifying Antirheumatic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Disease-Modifying Antirheumatic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2019-2024) & (MT)
Table 42. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2025-2030) & (MT)
Table 43. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Disease-Modifying Antirheumatic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Disease-Modifying Antirheumatic Drug Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Disease-Modifying Antirheumatic Drug Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2019-2024)
Table 51. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2025-2030)
Table 52. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2019-2024)
Table 53. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type (2025-2030)
Table 54. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2019-2024)
Table 59. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2025-2030)
Table 60. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2019-2024)
Table 61. Global Disease-Modifying Antirheumatic Drug Sales (MT) by Application (2025-2030)
Table 62. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2019-2024)
Table 63. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application (2025-2030)
Table 64. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Disease-Modifying Antirheumatic Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Disease-Modifying Antirheumatic Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2019-2024)
Table 69. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. AbbVie Disease-Modifying Antirheumatic Drug Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Amgen Disease-Modifying Antirheumatic Drug Product
Table 79. Amgen Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Pfizer Disease-Modifying Antirheumatic Drug Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Roche Holding AG Corporation Information
Table 86. Roche Holding AG Description and Business Overview
Table 87. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Roche Holding AG Disease-Modifying Antirheumatic Drug Product
Table 89. Roche Holding AG Recent Developments/Updates
Table 90. Novartis International AG Corporation Information
Table 91. Novartis International AG Description and Business Overview
Table 92. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Novartis International AG Disease-Modifying Antirheumatic Drug Product
Table 94. Novartis International AG Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Business Overview
Table 102. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product
Table 104. Bristol-Myers Squibb Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Merck Disease-Modifying Antirheumatic Drug Product
Table 109. Merck Recent Developments/Updates
Table 110. UCB S.A. Corporation Information
Table 111. UCB S.A. Description and Business Overview
Table 112. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. UCB S.A. Disease-Modifying Antirheumatic Drug Product
Table 114. UCB S.A. Recent Developments/Updates
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Disease-Modifying Antirheumatic Drug Distributors List
Table 123. Disease-Modifying Antirheumatic Drug Customers List
Table 124. Disease-Modifying Antirheumatic Drug Market Trends
Table 125. Disease-Modifying Antirheumatic Drug Market Drivers
Table 126. Disease-Modifying Antirheumatic Drug Market Challenges
Table 127. Disease-Modifying Antirheumatic Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Disease-Modifying Antirheumatic Drug
Figure 2. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Share by Type in 2023 & 2030
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Steroidal Anti-Inflammatory Drugs Product Picture
Figure 6. Slow Acting Drug Product Picture
Figure 7. Immunological Preparation Product Picture
Figure 8. Global Disease-Modifying Antirheumatic Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Disease-Modifying Antirheumatic Drug Market Share by Application in 2023 & 2030
Figure 10. Pharmaceutical Industry
Figure 11. Hospital and Clinic
Figure 12. Other
Figure 13. Global Disease-Modifying Antirheumatic Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Disease-Modifying Antirheumatic Drug Market Size (2019-2030) & (US$ Million)
Figure 15. Global Disease-Modifying Antirheumatic Drug Sales (2019-2030) & (MT)
Figure 16. Global Disease-Modifying Antirheumatic Drug Average Price (USD/MT) & (2019-2030)
Figure 17. Disease-Modifying Antirheumatic Drug Report Years Considered
Figure 18. Disease-Modifying Antirheumatic Drug Sales Share by Manufacturers in 2023
Figure 19. Global Disease-Modifying Antirheumatic Drug Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Disease-Modifying Antirheumatic Drug Players: Market Share by Revenue in 2023
Figure 21. Disease-Modifying Antirheumatic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Disease-Modifying Antirheumatic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2019-2030)
Figure 24. North America Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2019-2030)
Figure 28. Europe Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2019-2030)
Figure 29. Germany Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Disease-Modifying Antirheumatic Drug Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Disease-Modifying Antirheumatic Drug Revenue Market Share by Region (2019-2030)
Figure 36. China Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2019-2030)
Figure 47. Latin America Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Disease-Modifying Antirheumatic Drug Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Disease-Modifying Antirheumatic Drug Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Disease-Modifying Antirheumatic Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Disease-Modifying Antirheumatic Drug by Type (2019-2030)
Figure 57. Global Revenue Market Share of Disease-Modifying Antirheumatic Drug by Type (2019-2030)
Figure 58. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Type (2019-2030)
Figure 59. Global Sales Market Share of Disease-Modifying Antirheumatic Drug by Application (2019-2030)
Figure 60. Global Revenue Market Share of Disease-Modifying Antirheumatic Drug by Application (2019-2030)
Figure 61. Global Disease-Modifying Antirheumatic Drug Price (USD/MT) by Application (2019-2030)
Figure 62. Disease-Modifying Antirheumatic Drug Value Chain
Figure 63. Disease-Modifying Antirheumatic Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
